Disclaimer: This site aggregates publicly available data from official government sources (FDA, ClinicalTrials.gov, PubMed, SEC EDGAR) for general reference only. It does NOT constitute medical advice, diagnosis, treatment recommendations, or investment advice.

FDA 510(k)

ADVANCE EMIT-AED ETHOSUXIMIDE

K-Number: K823745 · 1983-01-07

ApplicantSyva Co.
Decision Date1983-01-07
Product CodeDLF
Advisory CommitteeTX
DecisionSubstantially Equivalent

Device Summary

ADVANCE EMIT-AED ETHOSUXIMIDE is the device name listed in this FDA 510(k) record. The listed applicant is Syva Co.. It received FDA 510(k) clearance on 1983-01-07 under 510(k) number K823745. The device is classified under product code DLF. It was reviewed by the TX advisory panel. FDA Decision: Substantially Equivalent.

Frequently Asked Questions

What is the ADVANCE EMIT-AED ETHOSUXIMIDE?

ADVANCE EMIT-AED ETHOSUXIMIDE is a medical device that received FDA 510(k) clearance on 1983-01-07. The listed applicant is Syva Co.. The 510(k) number is K823745.

When did ADVANCE EMIT-AED ETHOSUXIMIDE receive FDA 510(k) clearance?

ADVANCE EMIT-AED ETHOSUXIMIDE received FDA 510(k) clearance on 1983-01-07, under 510(k) number K823745.

Who is the listed applicant for ADVANCE EMIT-AED ETHOSUXIMIDE?

The FDA 510(k) record lists Syva Co. as the applicant. This does not by itself establish the device manufacturer.

What is the FDA product code for ADVANCE EMIT-AED ETHOSUXIMIDE?

The FDA product code for ADVANCE EMIT-AED ETHOSUXIMIDE is DLF.

Related Clinical Trials

Related records are matched automatically using names, product codes, or other metadata. A match does not establish a verified clinical, scientific, corporate, or regulatory relationship; review the linked official sources.

NCT07608549FLASH Pilot Phase 1 Safety StudyNOT_YET_RECRUITINGNCT06562205PAP Systems External Clinical Studies (ECS)NOT_YET_RECRUITINGNCT06443177The Effect of Sympathetic Modulation on Cerebral Vasospasm Secondary to Aneurysmal Subarachnoid HemorrhageSUSPENDEDNCT07095751Artificial Intelligence-assisted Uro-Cam Catheter Assessment System for Diagnosing Bladder CancerNOT_YET_RECRUITING

Other records listing Syva Co. as applicant

Related records are matched automatically using names, product codes, or other metadata. A match does not establish a verified clinical, scientific, corporate, or regulatory relationship; review the linked official sources.

K011878EMIT (R) TOX SALICYLIC ASSAY, MODEL 7SO19UL, EMIT (R) TOX SALICYLIC ACID CALIBRATORS, MODEL 7S109ULK012257EMIT II PLUS MONOCLONAL AMPHETAMINE/METHAMPHETAMINE ASSAY MODEL OSR9C229K011947EMIT 2000 VALPROIC ACID ASSAY, MODEL OSR4G229ULK011528EMIT 2000 PHENOBARBITAL ASSAY, MODEL OSR4D229K011347EMIT 2000 PHENYTOIN ASSAY, MODEL 0SR4A229K993980SYVA EMIT II PLUS ETHYL ALCOHOL ASSAY, MODELS 9K309UL/9K409UL

View all 448 devices →

Related Devices (Code: DLF)

Related records are matched automatically using names, product codes, or other metadata. A match does not establish a verified clinical, scientific, corporate, or regulatory relationship; review the linked official sources.

K881607EASY-TEST EMIT(R) ETHOSUXIMIDE (ETHS) ITEM 16647Em Diagnostic Systems, Inc.K850174TDX ETHOSUXIMIDEAbbott LaboratoriesK844204EMIT QST ETHOSUXIMIDE ASSAYSyva Co.K832797MODIFICA- OF EMIT AED ETHOSUXIMIDE ASSAYSyva Co.K823801AMES TDA ETHOSUXIMIDE TESTMiles Laboratories, Inc.K792584ACA ETHOSURIMIDE TEST PACKE.I. Dupont DE Nemours & Co., Inc.

Official Source

View on FDA Database →

Data sourced from FDA Open API. For the most current and authoritative information, always refer to the official record.

↑